Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3731 3771 3794 3796
This examiner grants 72% of resolved cases
Jocelin C Tanner is a high-volume examiner in Art Unit 3731 within Tech Center 3700. With 1059 resolved cases, the examiner maintains an allowance rate of 72.2 percent. This high rate suggests a favorable environment for obtaining a patent grant. The interview lift is 34.8 percent, indicating that interviews are a highly effective tool for moving cases toward allowance. Practitioners should prioritize the 34.8 percent interview lift to enhance the probability of success.
The median days to allowance is 1158. This duration serves as a benchmark for the time required to reach a successful conclusion. The 72.2 percent allowance rate and 1158-day median provide a clear statistical context for managing applications. These metrics, derived from 1059 resolved cases, offer a high degree of statistical reliability. Applicants can use the 1158-day median to set realistic expectations for their applications in Tech Center 3700.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18923876 | UTERINE MANIPULATOR INCLUDING POSITION SENSOR | Non-Final OA | Covidien LP |
| 19211803 | ASPIRATION MEDICAL DEVICE | Non-Final OA | BOSTON SCIENTIFIC SCIMED, INC. |
| 18776952 | EXPANDING FOAM DELIVERY SYSTEM FOR OCCLUDING LEFT ATRIAL APPENDAGE | Non-Final OA | BOSTON SCIENTIFIC SCIMED, INC. |
| 18741023 | INTRAVASCULAR LITHOTRIPSY DEVICE WITH PLASMA GENERATOR INCLUDING POLYMERIC MATERIAL | Non-Final OA | Boston Scientific Scimed, Inc. |
| 19177237 | Method and Articles for Treating the Sinus System | Non-Final OA | Stryker Corporation |
| 18999142 | CLOSURE DEVICES AND METHODS | Non-Final OA | Abbott Cardiovascular Systems, Inc. |
| 18822844 | PROSTHETIC HEART VALVE | Non-Final OA | EDWARDS LIFESCIENCES CORPORATION |
| 18906647 | REDUCER FOR CRITICAL LIMB ISCHEMIA AND CRITICAL HAND ISCHEMIA | Final Rejection | Cardiovascular Systems, Inc. |
| 19037061 | CATHETER WITH INTEGRATED EMBOLIC PROTECTION DEVICE | Non-Final OA | Emboline, Inc. |
| 18292350 | CARDIAC LEAD EXTRACTION DEVICE | Non-Final OA | Xcardia Innovation Ltd |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy